SCM
MDCO

Shelton Capital Management’s Medicines Co MDCO Stock Holding History

Shelton Capital Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-5,305
Closed -$451K – 869
2019
Q4 		$451K Sell
5,305
-1,200
-18% -$80K 0.02% 386
2019
Q3 		$325K Hold
6,505
– – 0.02% 495
2019
Q2 		$237K Buy
+6,505
New +$212K 0.01% 686
2018
Q3 		– Sell
-6,505
Closed -$239K – 950
2018
Q2 		$239K Hold
6,505
– – 0.01% 705
2018
Q1 		$214K Buy
+6,505
New +$203K 0.01% 747
2017
Q4 		– Sell
-6,505
Closed -$241K – 878
2017
Q3 		$241K Sell
6,505
-586
-8% -$21.6K 0.02% 692
2017
Q2 		$270K Buy
7,091
+775
+12% +$34.5K 0.02% 636
2017
Q1 		$309K Buy
+6,316
New +$288K 0.02% 562
2016
Q4 		– Sell
-5,825
Closed -$220K – 902
2016
Q3 		$220K Buy
+5,825
New +$220K 0.02% 710

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Shelton Capital Management's MDCO Position: Q1 2020 in Review

Shelton Capital Management sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 5,305 shares — an estimated $451K sold.

Shelton Capital Management first reported a position in MDCO in Q3 2016 and held it in 9 quarters. The position peaked at $451K in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Shelton Capital Management reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Shelton Capital Management sold 5,305 Medicines Co shares in Q1 2020, an estimated $451K.
  • Shelton Capital Management first reported a position in Medicines Co in Q3 2016 and held it in 9 quarters.
  • Shelton Capital Management's Medicines Co position peaked at $451K in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Shelton Capital Management's 13F filing for Q1 2020, filed 13 May 2020.